Back

Beta-blocker duration and long-term cardiovascular risk after myocardial infarction with reduced ejection fraction

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Post-myocardial infarction management Beta-Blockers ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Si Fang

University of Bristol, Bristol (United Kingdom of Great Britain & Northern Ireland)

5 More presentations in this session

Presentation thumbnail
Beta-blockers improved cardiovascular outcome in AMI patients with severe heart failure: a multi-center real-world study
Doctor R. Guo (Tianjin, CN)
Abstract Slides Video
Presentation thumbnail
Antithrombotic therapy in patients with takotsubo cardiomyopathy: is heparin associated with lower mortality? - a nationwide cohort analysis
Doctor S. Hijikata (Tokyo, JP)
Abstract Slides Video
Presentation thumbnail
Proton pump inhibitors in myocardial infarction: safety paradox in Type 1 vs. Type 2---a multicenter retrospective cohort study
Doctor J. Ren (Tianjin, CN)
Abstract Slides Video
Presentation thumbnail
Relationship between baseline LDL cholesterol levels and cardiovascular outcomes in adults with cardiovascular disease and overweight or obesity: an exploratory analysis of the SELECT trial
Professor M. Shechter (Ramat Gan, IL)
Abstract Slides Video
Presentation thumbnail
Effect of oral semaglutide on CV outcomes across the vascular disease spectrum, from no vascular disease to polyvascular disease, in high-risk type 2 diabetes
Associate Professor M. Cavender (Chapel Hill, US)
Abstract Slides

Access the full session

Session thumbnail
Post-myocardial infarction management

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
The effect of discontinuing long-term beta-blockers following acute myocardial infarction in optimally treated, stable patients without heart failure - a Danish, nationwide cohort study
thumbnail
Congress Presentation
Mortality effects of beta-blockers on myocardial infarction in patients without reduced ejection fraction or heart failure in the contemporary reperfusion era : a systematic review and meta-analysis
thumbnail
Congress Presentation
Impact of beta-blocker therapy in patients with preserved left ventricular ejection fraction after ST-segment elevation myocardial infarction

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources